![Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-019-0263-z/MediaObjects/41408_2019_263_Fig1_HTML.png)
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal
![The Attack of the Clones: The Armamentarium of Tests to Find Monoclonal Proteins - Renal Fellow Network The Attack of the Clones: The Armamentarium of Tests to Find Monoclonal Proteins - Renal Fellow Network](https://www.renalfellow.org/wp-content/uploads/2019/02/Fig1.png)
The Attack of the Clones: The Armamentarium of Tests to Find Monoclonal Proteins - Renal Fellow Network
![Challenges of measuring monoclonal proteins in serum in: Clinical Chemistry and Laboratory Medicine (CCLM) Volume 54 Issue 6 (2016) Challenges of measuring monoclonal proteins in serum in: Clinical Chemistry and Laboratory Medicine (CCLM) Volume 54 Issue 6 (2016)](https://www.degruyter.com/view/journals/cclm/54/6/graphic/j_cclm-2015-0862_fig_001.jpg)
Challenges of measuring monoclonal proteins in serum in: Clinical Chemistry and Laboratory Medicine (CCLM) Volume 54 Issue 6 (2016)
![Elotuzumab: serum protein electrophoresis and immunofixation interference with clinical assessment of M-protein response in relapsed/refractory multiple myeloma (RRMM) - Clinical Lymphoma, Myeloma and Leukemia Elotuzumab: serum protein electrophoresis and immunofixation interference with clinical assessment of M-protein response in relapsed/refractory multiple myeloma (RRMM) - Clinical Lymphoma, Myeloma and Leukemia](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e021233e-e936-4d23-9cd0-22d608c5fb4e/fx1.jpg)
Elotuzumab: serum protein electrophoresis and immunofixation interference with clinical assessment of M-protein response in relapsed/refractory multiple myeloma (RRMM) - Clinical Lymphoma, Myeloma and Leukemia
![Diagnostics | Free Full-Text | Complete Depletion of Daratumumab Interference in Serum Samples from Plasma Cell Myeloma Patients Improves the Detection of Endogenous M-Proteins in a Preliminary Study | HTML Diagnostics | Free Full-Text | Complete Depletion of Daratumumab Interference in Serum Samples from Plasma Cell Myeloma Patients Improves the Detection of Endogenous M-Proteins in a Preliminary Study | HTML](https://www.mdpi.com/diagnostics/diagnostics-10-00219/article_deploy/html/images/diagnostics-10-00219-g003.png)
Diagnostics | Free Full-Text | Complete Depletion of Daratumumab Interference in Serum Samples from Plasma Cell Myeloma Patients Improves the Detection of Endogenous M-Proteins in a Preliminary Study | HTML
![Immunoglobulin G kappa biclonal gammopathy associated with multiple myeloma, plasmacytoma and cast nephropathy Pradhan D, Arora P, Gami A, Kaur N - J Can Res Ther Immunoglobulin G kappa biclonal gammopathy associated with multiple myeloma, plasmacytoma and cast nephropathy Pradhan D, Arora P, Gami A, Kaur N - J Can Res Ther](https://www.cancerjournal.net/articles/2015/11/3/images/JCanResTher_2015_11_3_660_139379_f5.jpg)